Real-world Effectiveness and Safety of Lebrikizumab in Atopic Dermatitis: A TREATgermany Analysis.

Kind B, Pham C, Heinrich L, Honstein T, Heratizadeh A, Harder I, Stölzl D, Staubach-Renz P, Schaefer T, Abraham S, Augustin M, Ramaker-Brunke J, Pinter A, Meinhardt K, Quist S, Anders S, Schwarz B, Schulz-Kiesow M, Steinke S, Adler N, Handrick C, Schaekel K, Sticherling M, Bong A, Jacobs FD, Großmann B, Stahl M, Buerkle CP, Gorriahn-Maiterth HL, Biedermann T, Schmitt J, Weidinger S, Werfel T

Open source

DOI: 10.2340/actadv.v106.adv-2026-0542
Published: 2026 Aug 13
Container: Acta dermato-venereologica
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2340/actadv.v106.adv-2026-0542,
  title = {Real-world Effectiveness and Safety of Lebrikizumab in Atopic Dermatitis: A TREATgermany Analysis.},
  author = {Kind B and Pham C and Heinrich L and Honstein T and Heratizadeh A and Harder I and Stölzl D and Staubach-Renz P and Schaefer T and Abraham S and Augustin M and Ramaker-Brunke J and Pinter A and Meinhardt K and Quist S and Anders S and Schwarz B and Schulz-Kiesow M and Steinke S and Adler N and Handrick C and Schaekel K and Sticherling M and Bong A and Jacobs FD and Großmann B and Stahl M and Buerkle CP and Gorriahn-Maiterth HL and Biedermann T and Schmitt J and Weidinger S and Werfel T},
  year = {2026},
  journal = {Acta dermato-venereologica},
  doi = {10.2340/actadv.v106.adv-2026-0542},
  url = {https://doi.org/10.2340/actadv.v106.adv-2026-0542}
}

RIS

TY  - JOUR
TI  - Real-world Effectiveness and Safety of Lebrikizumab in Atopic Dermatitis: A TREATgermany Analysis.
AU  - Kind B
AU  - Pham C
AU  - Heinrich L
AU  - Honstein T
AU  - Heratizadeh A
AU  - Harder I
AU  - Stölzl D
AU  - Staubach-Renz P
AU  - Schaefer T
AU  - Abraham S
AU  - Augustin M
AU  - Ramaker-Brunke J
AU  - Pinter A
AU  - Meinhardt K
AU  - Quist S
AU  - Anders S
AU  - Schwarz B
AU  - Schulz-Kiesow M
AU  - Steinke S
AU  - Adler N
AU  - Handrick C
AU  - Schaekel K
AU  - Sticherling M
AU  - Bong A
AU  - Jacobs FD
AU  - Großmann B
AU  - Stahl M
AU  - Buerkle CP
AU  - Gorriahn-Maiterth HL
AU  - Biedermann T
AU  - Schmitt J
AU  - Weidinger S
AU  - Werfel T
PY  - 2026
JO  - Acta dermato-venereologica
DO  - 10.2340/actadv.v106.adv-2026-0542
UR  - https://doi.org/10.2340/actadv.v106.adv-2026-0542
ER  -

APA

B, K., C, P., L, H., T, H., A, H., I, H., D, S., P, S., T, S., S, A., M, A., J, R., A, P., K, M., S, Q., S, A., B, S., M, S., S, S., N, A., C, H., K, S., M, S., A, B., FD, J., B, G., M, S., CP, B., HL, G., T, B., J, S., S, W., & T, W. (2026). Real-world Effectiveness and Safety of Lebrikizumab in Atopic Dermatitis: A TREATgermany Analysis.. Acta dermato-venereologica. https://doi.org/10.2340/actadv.v106.adv-2026-0542

Source records

pubmed · retrieved 2026-09-26T00:39:12.840Z